Cargando…
P1192: ASIA SUBPOPULATION ANALYSIS FROM THE PHASE III POLARIX TRIAL
Autores principales: | Song, Y., Jin, J., Tilly, H., Zhang, H., Cao, J., Feng, J., Zhang, L., Rai, S., Goto, H., Terui, Y., Kim, W. S., Shin, H.-J., Gau, J.-P., Tsai, C.-H., Sharman, J. P., Bu, L., Hirata, J., Lee, C., Izutsu, K., Zhu, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429550/ http://dx.doi.org/10.1097/01.HS9.0000847632.22579.29 |
Ejemplares similares
-
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial
por: Song, Yuqin, et al.
Publicado: (2023) -
P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY
por: Trněný, M., et al.
Publicado: (2022) -
Status of the Polarix-TDS Project
por: Craievich, Paolo, et al.
Publicado: (2018) -
P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL
por: Morschhauser, F., et al.
Publicado: (2022) -
1192. H-NS-like Proteins in Pseudomonas aeruginosa Coordinately Silence Intragenic and Antisense Transcription
por: Lippa, Andrew M, et al.
Publicado: (2020)